ANI Pharmaceuticals, Inc. (ANIP) Net margin 2016–2025
ANI Pharmaceuticals, Inc. (ANIP) net profit margin by fiscal year — reported net income divided by reported revenue.
8.8%FY2025 · since FY2016: 3.1% → 8.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 8.8% | +11.9 pp |
| FY2024 | -3.1% | -7.0 pp |
| FY2023 | 3.9% | +19.1 pp |
| FY2022 | -15.2% | +4.7 pp |
| FY2021 | -19.9% | -9.1 pp |
| FY2020 | -10.8% | -13.8 pp |
| FY2019 | 3.0% | -4.7 pp |
| FY2018 | 7.7% | +8.3 pp |
| FY2017 | -0.6% | -3.7 pp |
| FY2016 | 3.1% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice